Free-Radical Toxicity and Antioxidant Medications in Parkinson's Disease
Open Access
- 1 March 1998
- journal article
- review article
- Published by Oxford University Press (OUP) in Physical Therapy
- Vol. 78 (3) , 313-319
Abstract
Parkinson's disease is a movement disorder characterized by the progressive degeneration of neurons located in the substantia nigra.1,2 These neurons synthesize and secrete dopamine, and the loss of dopaminergic influence on other structures in the basal ganglia leads to the classic parkinsonian symptoms of resting tremor, bradykinesia, rigidity, and postural instability.1,3 Pharmacologic treatment of Parkinson's disease traditionally has centered on administering medications that restore dopaminergic influence in the basal ganglia. The cornerstone of treatment usually consists of levodopa (L-dopa), which is the immediate precursor to dopamine.1,2 Levodopa crosses the blood-brain barrier, where it is then converted to dopamine, thus helping reestablish dopaminergic effects, The administration of L-dopa can often produce dramatic improvements in parkinsonian symptoms, especially during the early stages of the disease.1Keywords
This publication has 11 references indexed in Scilit:
- Scavenging Effects of Dopamine Agonists on Nitric Oxide RadicalsJournal of Neurochemistry, 1996
- Lazaroid Treatment Prevents Death of Cultured Rat Embryonic Mesencephalic Neurons Following Glutathione DepletionJournal of Neurochemistry, 1996
- Selegiline protects dopaminergic neurons in culture from toxic factor(s) present in the cerebrospinal fluid of patients with Parkinson's diseaseNeuroscience Letters, 1995
- Aging, energy, and oxidative stress in neurodegenerative diseasesAnnals of Neurology, 1995
- Neuroprotective therapeutic strategies comparison of experimental and clinical resultsBiochemical Pharmacology, 1995
- Rationale for (−)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changesBiomedicine & Pharmacotherapy, 1995
- Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitroBrain Research, 1994
- Free radicals in brain metabolism and pathologyBritish Medical Bulletin, 1993
- The possible role of iron in the etiopathology of parkinson's diseaseMovement Disorders, 1993
- Does Oxidative Stress Participate in Nerve Cell Death in Parkinson’s Disease?European Neurology, 1993